| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.961 | 33.151 | 36.121 | 43.135 | 50.068 | 48.189 | 57.467 | 67.397 | 91.216 |
| Total Income - EUR | - | 3.961 | 33.154 | 36.133 | 43.141 | 52.144 | 48.206 | 57.741 | 67.416 | 91.230 |
| Total Expenses - EUR | - | 2.780 | 16.128 | 18.351 | 22.077 | 30.927 | 33.822 | 33.425 | 42.578 | 60.448 |
| Gross Profit/Loss - EUR | - | 1.181 | 17.026 | 17.783 | 21.064 | 21.217 | 14.383 | 24.316 | 24.838 | 30.782 |
| Net Profit/Loss - EUR | - | 1.141 | 16.695 | 17.421 | 20.632 | 20.896 | 13.957 | 23.752 | 24.211 | 25.706 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Mateaşmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 110 | 0 | 10 | 0 | 372 | -31 | 0 | 1.639 | 2.162 |
| Current Assets | - | 4.047 | 20.989 | 19.325 | 24.458 | 25.928 | 19.580 | 45.259 | 29.240 | 31.406 |
| Inventories | - | 49 | 136 | 0 | 0 | 0 | 397 | 0 | 0 | 36 |
| Receivables | - | 2.433 | 3.268 | 4.159 | 131 | 4.732 | 5.698 | 21.990 | 10.480 | 41 |
| Cash | - | 1.566 | 17.586 | 15.165 | 24.328 | 21.195 | 13.485 | 23.268 | 18.760 | 31.329 |
| Shareholders Funds | - | 1.186 | 17.861 | 17.465 | 22.270 | 21.246 | 15.628 | 23.792 | 24.252 | 25.747 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.972 | 3.128 | 1.870 | 2.188 | 5.053 | 3.921 | 21.466 | 6.627 | 7.821 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Mateaşmed Srl